Investigational Drug Information for Brilacidin
✉ Email this page to a colleague
What is the drug development status for Brilacidin?
Brilacidin is an investigational drug.
There have been 4 clinical trials for Brilacidin.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 22nd 2021.
The most common disease conditions in clinical trials are Mouth Diseases, Bacterial Infections, and Head and Neck Neoplasms. The leading clinical trial sponsors are Innovation Pharmaceuticals, Inc., Cellceutix Corporation, and [disabled in preview].
There are seventeen US patents protecting this investigational drug and four hundred and two international patents.
Summary for Brilacidin
US Patents | 17 |
International Patents | 402 |
US Patent Applications | 58 |
WIPO Patent Applications | 49 |
Japanese Patent Applications | 4 |
Clinical Trial Progress | Phase 2 (2021-02-22) |
Vendors | 21 |
Recent Clinical Trials for Brilacidin
Title | Sponsor | Phase |
---|---|---|
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | Innovation Pharmaceuticals, Inc. | Phase 2 |
A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers | Innovation Pharmaceuticals, Inc. | Phase 1 |
Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | Cellceutix Corporation | Phase 2 |
Clinical Trial Summary for Brilacidin
Top disease conditions for Brilacidin
Top clinical trial sponsors for Brilacidin
US Patents for Brilacidin
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Brilacidin | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
Brilacidin | ⤷ Try a Trial | Arylamide compounds and compositions and uses thereof | Innovation Pharmaceuticals Inc. (Beverly, MA) | ⤷ Try a Trial |
Brilacidin | ⤷ Try a Trial | Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof | Redwood Bioscience, Inc. (Emeryville, CA) | ⤷ Try a Trial |
Brilacidin | ⤷ Try a Trial | Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate | R.P. Scherer Technologies, LLC (Carson City, NV) | ⤷ Try a Trial |
Brilacidin | ⤷ Try a Trial | Pharmaceutical glass packaging assuring pharmaceutical sterility | Corning Incorporated (Corning, NY) | ⤷ Try a Trial |
Brilacidin | ⤷ Try a Trial | Compositions and methods for single molecular placement on a substrate | ILLUMINA, INC. (San Diego, CA) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Brilacidin
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Brilacidin | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
Brilacidin | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
Brilacidin | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
Brilacidin | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Try a Trial |
Brilacidin | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Try a Trial |
Brilacidin | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |